Tapewire

Nasdaq · USD

COCP

Cocrystal Pharma, Inc.

Export transactions ↓
Tapewire entity
7621
SEC CIK
0001412486
Parsed reports
90

Last 12 months

Inside the activity.

11 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202540
Jan 202600
Feb 202620
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 25, 2022 Filed Aug 3, 2022 20:02 UTC GrantStock Options (Right to Buy) · Derivative 188,000 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001493152-22-021149 · ownership.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,000

Underlying: Common Stock · 188,000 shares

Expires 2032-07-25

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
July 25, 2022 Filed Aug 3, 2022 20:03 UTC GrantStock Options (Right to Buy) · Derivative 80,000 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001493152-22-021151 · ownership.xml · derivative · entry 1

PFENNIGER RICHARD C JR · CIK 0001200796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2032-07-25

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
August 20, 2021 Filed Aug 23, 2021 22:02 UTC PurchaseCommon Stock 40,000 $1.03 $41,120.00
Disclosure

SEC source: 0001493152-21-021048 · ownership.xml · nonDerivative · entry 1

PFENNIGER RICHARD C JR · CIK 0001200796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions ranging from $1.02 to $1.03, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in the preceding sentence.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 20:05 UTC GrantStock Options (Right to Buy) · Derivative 65,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017330 · ownership.xml · derivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2031-07-16

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 16:06 UTC GrantStock Options (Right to Buy) · Derivative 65,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017328 · ownership.xml · derivative · entry 1

Kornberg Roger D. · CIK 0001444532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2031-07-16

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 20:06 UTC GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017325 · ownership.xml · derivative · entry 1

PFENNIGER RICHARD C JR · CIK 0001200796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-07-16

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 20:06 UTC
Martin James JosephChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 250,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017327 · ownership.xml · derivative · entry 1

Martin James Joseph · CIK 0001510224 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2031-07-16

F1 · security: The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the "Code").

F2 · derivative.exercise_date: The stock options vest and become exercisable as follows, subject in each case to the limitations on exercisability of incentive stock options under Section 422 of the Code: one-half will vest on July 16, 2022 and the remaining half will vest in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to continued employment on each applicable vesting date.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 20:05 UTC GrantStock Options (Right to Buy) · Derivative 88,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017326 · ownership.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,000

Underlying: Common Stock · 88,000 shares

Expires 2031-07-16

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 20:05 UTC GrantStock Options (Right to Buy) · Derivative 74,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017324 · ownership.xml · derivative · entry 1

Japour Anthony J · CIK 0001773088 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,000

Underlying: Common Stock · 74,000 shares

Expires 2031-07-16

F1 · derivative.exercise_date: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 20:05 UTC
Lee SamPresident and Co-Interim CEO
GrantStock Options (Right to Buy) · Derivative 250,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001493152-21-017331 · ownership.xml · derivative · entry 1

Lee Sam · CIK 0001602074 · President and Co-Interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2031-07-16

F1 · security: The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the "Code").

F2 · derivative.exercise_date: The stock options vest and become exercisable as follows, subject in each case to the limitations on exercisability of incentive stock options under Section 422 of the Code: one-half will vest on July 16, 2022 and the remaining half will vest in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to continued employment on each applicable vesting date.

Read SEC document
May 04, 2021 Filed May 6, 2021 22:00 UTC SaleCommon Stock 575,000 $2.95 $1,696,250.00
Disclosure

SEC source: 0001493152-21-010669 · ownership.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,674,960

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $2.60 to $3.25, inclusive. The Reporting Person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
November 24, 2020 Filed Feb 12, 2021 22:02 UTC
Lee SamPresident
GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.30 $0.00
Disclosure

SEC source: 0001493152-21-003686 · ownership.xml · derivative · entry 1

Lee Sam · CIK 0001602074 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-11-24

F1 · security: The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code.

F2 · derivative.exercise_date: The stock options vest as follows: 25,000 incentive stock options will vest on the one year anniversary of the grant date and the remaining 25,000 incentive stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on February 28, 2022, subject to continued employment on each applicable vesting date.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:05 UTC GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011716 · ownership.xml · derivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The stock options vest as follows: 25,000 stock options will vest on the one year anniversary of the grant date and the remaining 25,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 16:54 UTC GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011730 · ownership.xml · derivative · entry 1

Kornberg Roger D. · CIK 0001444532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The stock options vest as follows: 25,000 stock options will vest on the one year anniversary of the grant date and the remaining 25,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 22:52 UTC
Lee SamPresident
GrantStock Options (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011752 · ownership.xml · derivative · entry 1

Lee Sam · CIK 0001602074 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-06-22

F1 · security: The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code.

F2 · derivative.exercise_date: The stock options vest as follows: 50,000 stock options will vest on the one year anniversary of the grant date and the remaining 50,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 22:50 UTC GrantStock Options (Right to Buy) · Derivative 56,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011751 · ownership.xml · derivative · entry 1

Japour Anthony J · CIK 0001773088 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Common Stock · 56,000 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The stock options vest as follows: 28,000 stock options will vest on the one year anniversary of the grant date and the remaining 28,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:05 UTC
Martin James JosephChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011718 · ownership.xml · derivative · entry 1

Martin James Joseph · CIK 0001510224 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2030-06-22

F1 · security: The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code.

F2 · derivative.exercise_date: The stock options vest as follows: 75,000 stock options will vest on the one year anniversary of the grant date and the remaining 75,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 22:12 UTC
WILCOX GARYChief Executive Officer
GrantStock Options (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011748 · ownership.xml · derivative · entry 1

WILCOX GARY · CIK 0001222257 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2030-06-22

F1 · security: The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year.

F2 · derivative.exercise_date: The stock options vest as follows: 100,000 stock options will vest on the one year anniversary of the grant date and the remaining 100,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:05 UTC GrantStock Options (Right to Buy) · Derivative 72,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001493152-20-011715 · ownership.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,000

Underlying: Common Stock · 72,000 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The stock options vest as follows: 36,000 stock options will vest on the one year anniversary of the grant date and the remaining 36,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.

Read SEC document
October 25, 2019 Filed Oct 29, 2019 21:03 UTC PurchaseCommon Stock 7,906 $1.15 $9,091.90
Disclosure

SEC source: 0001493152-19-016105 · ownership.xml · nonDerivative · entry 3

Schinazi Raymond F · CIK 0001397607 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,257,863

Read SEC document
October 24, 2019 Filed Oct 29, 2019 21:03 UTC PurchaseCommon Stock 5,094 $1.15 $5,858.10
Disclosure

SEC source: 0001493152-19-016105 · ownership.xml · nonDerivative · entry 2

Schinazi Raymond F · CIK 0001397607 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,249,957

Read SEC document
October 23, 2019 Filed Oct 29, 2019 21:03 UTC PurchaseCommon Stock 3,935 $1.04 $4,086.89
Disclosure

SEC source: 0001493152-19-016105 · ownership.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,244,863

F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.965 to $1.08, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnote of this Form 4.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 20:46 UTC
FROST PHILLIP MD ET ALDirector · 10% owner
GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013667 · ownership.xml · derivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-09-20

F1 · derivative.exercise_date: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 20:56 UTC GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013674 · ownership.xml · derivative · entry 1

HSIAO JANE PH D · CIK 0001188834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-09-20

F1 · derivative.exercise_date: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 20:52 UTC
Lee SamPresident
GrantStock Options (Right to Buy) · Derivative 100,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013671 · ownership.xml · derivative · entry 1

Lee Sam · CIK 0001602074 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-09-20

F1 · security: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

F2 · derivative.exercise_date: The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 20:49 UTC GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013669 · ownership.xml · derivative · entry 1

Rubin Steven D · CIK 0001381874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-09-20

F1 · derivative.exercise_date: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 20:43 UTC
Schinazi Raymond FDirector · 10% owner
GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013665 · ownership.xml · derivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-09-20

F1 · derivative.exercise_date: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 13:29 UTC GrantStock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013626 · ownership.xml · derivative · entry 1

BLOCK DAVID S · CIK 0001222646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-09-20

F1 · derivative.exercise_date: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 13:00 UTC
WILCOX GARYDirector · Interim CEO
GrantStock Options (Right to Buy) · Derivative 200,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013623 · ownership.xml · derivative · entry 1

WILCOX GARY · CIK 0001222257 · Director · Interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2028-09-20

F1 · security: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

F2 · derivative.exercise_date: The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 13:00 UTC
Martin James JosephChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 150,000 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001493152-18-013622 · ownership.xml · derivative · entry 1

Martin James Joseph · CIK 0001510224 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-09-20

F1 · security: The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments.

F2 · derivative.exercise_date: The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year.

Read SEC document
May 10, 2018 Filed May 14, 2018 20:01 UTC
Schinazi Raymond FDirector · 10% owner
Exercise / conversion8% Convertible Note · Derivative 263,158 $500,000.00 Strike: $1.90 $131,579,000,000.00
Disclosure

SEC source: 0001493152-18-006784 · form4.xml · derivative · entry 6

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 263,158

Underlying: Common Stock · 263,158 shares

Expires 2019-11-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The amount of securities beneficially owned and the conversion prices have been adjusted for the one-for-30 reverse stock split effective January 24, 2018.

Read SEC document
May 10, 2018 Filed May 14, 2018 20:01 UTC
Schinazi Raymond FDirector · 10% owner
Grant8% Convertible Note · Derivative 263,158 $500,000.00 Strike: $1.90 $131,579,000,000.00
Disclosure

SEC source: 0001493152-18-006784 · form4.xml · derivative · entry 5

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 263,158

Underlying: Common Stock · 263,158 shares

Expires 2019-11-24

F1 · security: The amount of securities beneficially owned and the conversion prices have been adjusted for the one-for-30 reverse stock split effective January 24, 2018.

F4 · security: In accordance with Rule 16b-3, in advance of the effectuation of the transactions reported, the issuer's board of directors approved an amendment to the convertible note held by the reporting person who is a director and 10% beneficial owner of the issuer. The amendment of the outstanding convertible note is reported as a cancellation of the "old" note and the grant of a replacement note.

Read SEC document
May 10, 2018 Filed May 14, 2018 20:01 UTC
Schinazi Raymond FDirector · 10% owner
Disposition to issuer8% Convertible Note · Derivative 61,728 $500,000.00 Strike: $8.10 $30,864,000,000.00
Disclosure

SEC source: 0001493152-18-006784 · form4.xml · derivative · entry 4

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 61,728

Underlying: Common Stock · 61,728 shares

Expires 2019-11-24

F1 · security: The amount of securities beneficially owned and the conversion prices have been adjusted for the one-for-30 reverse stock split effective January 24, 2018.

F4 · security: In accordance with Rule 16b-3, in advance of the effectuation of the transactions reported, the issuer's board of directors approved an amendment to the convertible note held by the reporting person who is a director and 10% beneficial owner of the issuer. The amendment of the outstanding convertible note is reported as a cancellation of the "old" note and the grant of a replacement note.

Read SEC document
May 10, 2018 Filed May 14, 2018 20:01 UTC
Schinazi Raymond FDirector · 10% owner
GrantCommon Stock 10,209 $1.90 $19,397.10
Disclosure

SEC source: 0001493152-18-006784 · form4.xml · nonDerivative · entry 2

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 995,593

F1 · security: The amount of securities beneficially owned and the conversion prices have been adjusted for the one-for-30 reverse stock split effective January 24, 2018.

F3 · kind: The reporting person was issued common stock in lieu of accrued interest owed in connection with the convertible note described in Table II.

Read SEC document
May 10, 2018 Filed May 14, 2018 20:01 UTC
Schinazi Raymond FDirector · 10% owner
Exercise / conversionCommon Stock 263,158 $1.90 $500,000.20
Disclosure

SEC source: 0001493152-18-006784 · form4.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 985,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The amount of securities beneficially owned and the conversion prices have been adjusted for the one-for-30 reverse stock split effective January 24, 2018.

F2 · kind: The reporting person was issued common stock in connection with the conversion of a convertible note, as amended, at $1.90 per share. See Table II for a description of the convertible note.

Read SEC document
May 03, 2018 Filed May 7, 2018 21:06 UTC
FROST PHILLIP MD ET ALDirector · 10% owner
GrantCommon Stock 105,263 $1.90 $199,999.70
Disclosure

SEC source: 0001493152-18-006346 · form4.xml · nonDerivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · Director · 10% owner

Frost Gamma Investments Trust · CIK 0001380896 · Trustee

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Frost Gamma Investments Trust

Disclosed balance after: 3,655,265

F1 · shares: These securities were purchased in the Issuer's public offering.

F2 · balance_after: The amount of securities beneficially owned has been adjusted for the one for 30 reverse stock split effective January 24, 2018.

F3 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. Dr. Frost disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that Dr. Frost is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 03, 2018 Filed May 7, 2018 22:21 UTC
Schinazi Raymond FDirector · 10% owner
GrantCommon Stock 420,737 $1.90 $799,400.30
Disclosure

SEC source: 0001493152-18-006360 · form4.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 722,226

Read SEC document
November 24, 2017 Filed Dec 8, 2017 22:42 UTC Grant8% Convertible Note · Derivative 1,851,851 $500,000.00 Strike: $0.27 $925,925,500,000.00
Disclosure

SEC source: 0001493152-17-014433 · form4.xml · derivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 1,851,851

Underlying: Common Stock · 1,851,851 shares

Expires 2019-11-24

Read SEC document
July 11, 2017 Filed Jul 13, 2017 20:05 UTC
Schinazi Raymond FDirector · 10% owner
Exercise / conversionStock Options (Right to Buy) · Derivative 1,706,978 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001493152-17-007777 · form4.xml · derivative · entry 3

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,706,978 shares

Expires 2018-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 11, 2017 Filed Jul 13, 2017 20:05 UTC
Schinazi Raymond FDirector · 10% owner
Exercise / conversionCommon Stock 1,706,978 $0.05 $80,227.97
Disclosure

SEC source: 0001493152-17-007777 · form4.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,227,831

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 20:15 UTC
Schinazi Raymond FDirector · 10% owner
GrantCommon Stock 4,166,667 $0.24 $1,000,000.08
Disclosure

SEC source: 0001493152-17-004329 · form4.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LLC

Disclosed balance after: 9,044,717

F1 · kind: Represents a purchase meeting the requirements of Rule 16b-3.

Read SEC document
December 23, 2016 Filed Dec 23, 2016 21:05 UTC
Lee SamPRESIDENT
SaleCommon Stock 2,200,000 $0.44 $968,000.00
Disclosure

SEC source: 0001415889-16-007631 · form4-12232016_041201.xml · nonDerivative · entry 1

Lee Sam · CIK 0001602074 · PRESIDENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,087,847

Read SEC document
September 01, 2016 Filed Sep 6, 2016 20:15 UTC PurchaseCommon Stock 10,000 $0.41 $4,100.00
Disclosure

SEC source: 0001415889-16-007052 · form4-09062016_040909.xml · nonDerivative · entry 1

BLOCK DAVID S · CIK 0001222646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,696

Read SEC document
September 01, 2016 Filed Sep 6, 2016 20:15 UTC
WILCOX GARYDirector · INTERIM CEO
PurchaseCommon Stock 10,000 $0.41 $4,100.00
Disclosure

SEC source: 0001415889-16-007050 · form4-09062016_040901.xml · nonDerivative · entry 1

WILCOX GARY · CIK 0001222257 · Director · INTERIM CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 16,948,605

Read SEC document
September 01, 2016 Filed Sep 6, 2016 20:15 UTC
Schinazi Raymond FDirector · 10% owner
PurchaseCommon Stock 4,878,050 $0.41 $2,000,000.50
Disclosure

SEC source: 0001415889-16-007051 · form4-09062016_040905.xml · nonDerivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LLC

Disclosed balance after: 4,878,050

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.